Evidence map›Paper›PMID 24576496›Full record

ArticleNeurochemistry international2014

Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.

Yvette Dehnes, Jufang Shan, Thijs Beuming, Lei Shi, Harel Weinstein, Jonathan A Javitch

Abstract read
In one paragraph

Article in Neurochemistry international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Yvette DehnesCenter for Molecular Recognition, Columbia University College of Physicians and Surgeons, 630 W. 168th, New York, NY 10032, USA; Center for Molecular Biology and Neuroscience, Department of Anatomy, Institute of Basic Medical Sciences, University of Oslo, PO Box 1105 Blindern, N 0317 Oslo, Norway. Electronic address: yvette.dehnes@h-lab.no.
Jufang ShanDepartment of Physiology and Biophysics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA. Electronic address: jufang.shan@gmail.com.
Thijs BeumingDepartment of Physiology and Biophysics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA; Schrodinger, Inc., 120 West 45th Street, New York, NY 10036, USA. Electronic address: thijs.beuming@schrodinger.com.
Lei ShiDepartment of Physiology and Biophysics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA; HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Medical College of Cornell University, 1305 York Avenue, New York, NY 10021, USA. Electronic address: les2007@med.cornell.edu.
Harel WeinsteinDepartment of Physiology and Biophysics, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10065, USA; HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Medical College of Cornell University, 1305 York Avenue, New York, NY 10021, USA. Electronic address: haw2002@physbio-tech.net.
Jonathan A JavitchCenter for Molecular Recognition, Columbia University College of Physicians and Surgeons, 630 W. 168th, New York, NY 10032, USA; Department of Psychiatry & Pharmacology, Columbia University College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, USA; Division of Molecular Therapeutics, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA. Electronic address: jaj2@columbia.edu.
Cornell University · USColumbia University · USSchrodinger (United States) · USUniversity of Oslo · NO

Funding

Synthetic Antigen Binder CoreU54GM087519 · NIGMS · UNIVERSITY OF CHICAGO · PI PEROZO, EDUARDO A · 2010 to 2017
$31.9M
STRUCTURE/FUNCTION OF THE HUMAN DOPAMINE TRANSPORTERP01DA012408 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI WEINSTEIN, HAREL · 1999 to 2015
$14.2M
Molecular mechanisms of bacterial homologs of neurotransmitter:sodium symportersR01DA017293 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JAVITCH, JONATHAN A · 2003 to 2013
$4.9M
Molecular Determinants for the Action of PsychostimulantsK05DA022413 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JAVITCH, JONATHAN A · 2007 to 2016
$1.3M
The Neurotransmitter: Sodium Symporter Permeation PathwayR00DA023694 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHI, LEI · 2010 to 2012
$725k
The Neurotransmitter: Sodium Symporter Permeation PathwayK99DA023694 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SHI, LEI · 2008 to 2009
$180k
NIDA NIH HHS DA012408NIDA NIH HHS DA022413NIDA NIH HHS DA023694NIDA NIH HHS DA17293NIDA NIH HHS K05 DA022413NIDA NIH HHS K99 DA023694NIDA NIH HHS P01 DA012408NIDA NIH HHS R00 DA023694NIDA NIH HHS R01 DA017293NIGMS NIH HHS U54 GM087519NIGMS NIH HHS U54GM087519
6 · The paper itself

Abstract

The dopamine transporter (DAT), a member of the neurotransmitter:sodium symporter family, mediates the reuptake of dopamine at the synaptic cleft. DAT is the primary target for psychostimulants such as cocaine and amphetamine. We previously demonstrated that cocaine binding and dopamine transport alter the accessibility of Cys342 in the third intracellular loop (IL3). To study the conformational changes associated with the functional mechanism of the transporter, we made cysteine substitution mutants, one at a time, from Phe332 to Ser351 in IL3 of the background DAT construct, X7C, in which 7 endogenous cysteines were mutated. The accessibility of the 20 engineered cysteines to polar charged sulfhydryl reagents was studied in the absence and presence of cocaine or dopamine. Of the 11 positions that reacted with methanethiosulfonate ethyl ammonium, as evidenced by inhibition of ligand binding, 5 were protected against this inhibition by cocaine and dopamine (S333C, S334C, N336C, M342C and T349C), indicating that reagent accessibility is affected by conformational changes associated with inhibitor and substrate binding. In some of the cysteine mutants, transport activity is disrupted, but can be rescued by the presence of zinc, most likely because the distribution between inward- and outward-facing conformations is restored by zinc binding. The experimental data were interpreted in the context of molecular models of DAT in both the inward- and outward-facing conformations. Differences in the solvent accessible surface area for individual IL3 residues calculated for these states correlate well with the experimental accessibility data, and suggest that protection by ligand binding results from the stabilization of the outward-facing configuration. Changes in the residue interaction networks observed from the molecular dynamics simulations also revealed the critical roles of several positions during the conformational transitions. We conclude that the IL3 region of DAT undergoes significant conformational changes in transitions necessary for both cocaine binding and substrate transport.

Indexed as

Cloning, MolecularCocaineCysteineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsHEK293 CellsHumansProtein ConformationProtein TransportSulfhydryl ReagentsTropanesTyramineZinc2-carbomethoxy-3-(3',4'-dichlorophenyl)tropaneCocaineCysteineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsSulfhydryl ReagentsTropanesTyramineZincCocaine bindingCysteine accessibilityDopamine transportDopamine transporter (DAT)Molecular dynamics simulations

Identifiers

PMID24576496
PMCPMC4058377
OpenAlexW2050132312

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.